Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
04/29/2014 | US8710234 Amide derivatives, process for preparation thereof and use thereof as insecticide |
04/29/2014 | US8710222 2,4-disubstituted pyrimidines useful as kinase inhibitors |
04/29/2014 | US8710221 Process and intermediates for preparing lapatinib |
04/29/2014 | US8710098 Group of amino substituted benzoyl derivatives and their preparation and their use |
04/29/2014 | US8710044 Bicyclic azaheterocyclic carboxamides |
04/29/2014 | US8709993 Quinazoline compounds and their use in perfume compositions |
04/29/2014 | CA2655573C Therapeutic or prophylactic agent for multiple sclerosis |
04/29/2014 | CA2637631C Pyrimidine compounds and uses thereof |
04/29/2014 | CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
04/29/2014 | CA2570873C Pyrimidine urea derivatives as kinase inhibitors |
04/24/2014 | WO2014062811A2 METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2 |
04/24/2014 | WO2014062044A1 Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase |
04/24/2014 | WO2014060900A1 Process for the preparation of voriconazole and analogues thereof |
04/24/2014 | WO2014060588A1 2,3-dihydroquinazolin-4(1 h)-one derivatives for use in the treatment of viral infections |
04/24/2014 | WO2014060586A1 New compounds having a protective activity against toxins with intracellular activity |
04/24/2014 | WO2014060376A1 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group |
04/24/2014 | WO2014060371A1 Inhibitors of syk |
04/24/2014 | US20140113923 Novel antiviral therapies |
04/24/2014 | US20140113922 Compounds |
04/24/2014 | US20140113898 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers |
04/23/2014 | EP2722328A1 Novel compounds with protective activity against toxins with intracellular action mode |
04/23/2014 | EP2722047A1 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections |
04/23/2014 | CN103748106A Efficient peptide couplings and their use in the synthesis and isolation of cyclopenta (G) quinazoline trisodium salt |
04/23/2014 | CN103748081A Quinazoline derivatives for the treatment of viral infections and further diseases |
04/23/2014 | CN103739558A Method for preparing known impurities of gefitinib |
04/23/2014 | CN103739557A Synthetic method of 4,6-dimethyl-2-methyl sulfonyl pyridine |
04/23/2014 | CN103739556A Preparation method and detection method of 2,4-dibromopyrimidine |
04/23/2014 | CN103739546A Four-hydrogen-bond fullerene supramolecular polymer with stripped morphology and preparation method thereof |
04/23/2014 | CN103183644B Uracil zinc salt and application thereof as heat stabilizer for PVC |
04/23/2014 | CN102675226B 3-substituted-1-methyl-quinazoline-2,4-dione compounds, preparation method and application thereof |
04/22/2014 | US8703945 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
04/22/2014 | US8703944 Method for preparing rosuvastatin calcium intermediate |
04/22/2014 | US8703785 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
04/22/2014 | US8703782 Substituted indole derivatives |
04/22/2014 | US8703768 Nitrogen containing heteroaryl compounds |
04/22/2014 | US8703767 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors |
04/22/2014 | CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase |
04/22/2014 | CA2612227C Pyrimidine compounds |
04/17/2014 | WO2014058747A1 5-phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhibitors |
04/17/2014 | WO2014057080A2 Cyclic amines |
04/17/2014 | WO2014057078A1 Benzamides |
04/17/2014 | WO2014056760A1 Hair dye agent comprising aminopyrimidine derivatives |
04/17/2014 | WO2014056758A1 Hair dye agent comprising aminopyrimidine derivatives |
04/17/2014 | WO2014036528A3 Agents useful for treating obesity, diabetes and related disorders |
04/17/2014 | US20140107340 Benzamides |
04/17/2014 | US20140107335 Cyclic Amines |
04/17/2014 | US20140107160 Ccr9 inhibitors and methods of use thereof |
04/17/2014 | US20140107134 Compounds for inflammation and immune-related uses |
04/17/2014 | US20140107128 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
04/17/2014 | US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis |
04/16/2014 | EP2719395A1 Adsorption of immunopotentiators to insoluble metal salts |
04/16/2014 | EP2718270A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
04/16/2014 | CN103732578A Quinolinyl glucagon receptor modulators |
04/16/2014 | CN103732067A Compounds,compositions and therapeutic uses thereof |
04/16/2014 | CN103724331A Compound for treating cerebral palsy and use thereof |
04/16/2014 | CN103724282A Synthesis method of quinazoline derivatives as pharmaceutical intermediate |
04/16/2014 | CN103724281A Novel derivative of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl and application of novel derivative |
04/16/2014 | CN103724280A Compound for treating cerebral palsy and use thereof |
04/16/2014 | CN103724279A Portable synthesis method for preparing 2-methyl-4-amino-5-aminoethylpyrimidine through one-step cyclization reaction |
04/16/2014 | CN103724278A Preparation method for tatin intermediate and derivatives thereof |
04/16/2014 | CN103159684B Method for preparing 2-amino-4, 6-dimethoxypyrimidine |
04/16/2014 | CN102617486B Process for preparing 6-chlorine-1,3-dimethyl uracil |
04/16/2014 | CN102516182B Preparation method for 4-amino-6-alkoxyl pyrimidine compounds |
04/16/2014 | CN102408380B 5-aminopyrimidine-thione compounds and preparation method thereof |
04/16/2014 | CN102399197B 2-(2-hydroxy - substituted phenethyl sulfenyl]-3H-pyrimidin-4-ketone compounds and synthesis method and application thereof |
04/16/2014 | CN102311395B Quinazoline ring substituted diphenylurea derivative and its purpose |
04/16/2014 | CN101795566B Co-crystals of pyrimethanil and dithianon |
04/15/2014 | US8697869 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators |
04/15/2014 | US8697865 Cyclic amide derivative, and its production and use |
04/15/2014 | US8697717 Inhibitors of histone deacetylase |
04/15/2014 | US8697714 Quinazolinone based fluorogenic probes |
04/15/2014 | US8697697 Pyrazole derivatives as ERK inhibitors |
04/15/2014 | US8697694 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
04/15/2014 | US8697687 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives |
04/15/2014 | US8697685 Chemical compounds |
04/15/2014 | US8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
04/15/2014 | US8697256 Composition comprising phosphorescent compound and light emitting device using the composition |
04/10/2014 | WO2014053694A1 N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists |
04/10/2014 | WO2014053595A1 Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases |
04/10/2014 | WO2012118945A3 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
04/10/2014 | US20140100210 Guanidine compound |
04/10/2014 | US20140100195 Heterobicyclic sphingosine 1-phosphate analogs |
04/10/2014 | DE102012218459A1 Haarfärbemittel enthaltend Aminopyrimidinderivate Hair dyes containing aminopyrimidine derivatives |
04/09/2014 | EP2716633A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof |
04/09/2014 | EP2716292A1 Cdc42 inhibitor and uses thereof |
04/09/2014 | EP2714665A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof |
04/09/2014 | EP2714660A1 Neprilysin inhibitors |
04/09/2014 | EP2713755A1 Cyclohexanone compounds and herbicides comprising the same |
04/09/2014 | EP2713736A1 Novel immune system modulators |
04/09/2014 | CN103717070A Novel immune system modulators |
04/09/2014 | CN103709110A Preparation method of erlotinib hydrochloride key intermediate |
04/09/2014 | CN103709109A Preparation method of sulfadimidine hydrosulfate |
04/09/2014 | CN103709108A Production method of synthesizing 2-amino-4,6-dimethoxy pyrimidine |
04/09/2014 | CN103709107A Novel crystal form of rosuvastatin methyl ester, and preparation method thereof |
04/09/2014 | CN103709106A Stereoselectivity preparation method for Letairis |
04/09/2014 | CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application |
04/09/2014 | CN102698803B Ruthenium complex catalyst and preparation method and application thereof |
04/09/2014 | CN102659692B Double-linked Erlotinib and preparation method thereof |
04/09/2014 | CN102548965B Substituted amide compound |
04/09/2014 | CN102464622B Substituted pyrimidine ammine compound and application thereof |